This nationwide study highlights the prevalent use of oral glucocorticoids in French patients with SLE and shows that ...
A video of the incident showed a worker at the construction site hurrying to help the injured bikers at the end of the ...
Conduit Pharmaceuticals and Charles River Laboratories have announced a partnership to evaluate AZD1656, a glucokinase activator, in a preclinical model of systemic lupus erythematosus (SLE).
There are multiple chapters near you. Select your preferred chapter.
至今,我们已经发现了多个单基因的系统性红斑狼疮样疾病(monogenic systemic lupus erythematosus )。目前比较公认的有如下疾病:一,历史与简介最早是Schorr 等人于 1976 年首次描述 ...
Cabaletta’s new data slice for its investigational CD19-CAR T cell therapy shows “robust benefit” for patients with lupus and ...
Biogen has bagged $250 million to advance a key pipeline prospect. | Biogen has bagged $250 million to advance a key pipeline ...
In the United States, SLE treatment trends between 2007 and 2023 show a continued reliance on glucocorticoids, despite advances in steroid-sparing agents.
4d
HealthDay on MSNAnifrolumab Tied to Less Organ Damage for Patients With LupusFor patients with moderately to severely active systemic lupus erythematosus (SLE), anifrolumab is associated with l ...
A truck driver fled the scene of an accident after colliding with two motorcyclists on Monday night (Feb 17). The accident occurred along Seletar Expressway (SLE) towards Bukit Timah Expressway (BKE) ...
“This agreement highlights Biogen’s growing lupus portfolio and the potential of litifilimab, with its distinct mechanism of action, to address SLE and CLE – two forms of lupus where there are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results